Evidence map›Paper›PMID 40558077›Full record

SynthesisPsychiatry and clinical neurosciences2025

Diagnosis and symptom assessment in telepsychiatry vs. face-to-face settings: A systematic review and meta-analysis.

Mayu Fujikawa, Katsuhiko Hagi, Shotaro Kinoshita, Akihiro Takamiya, Mari Iizuka, Shota Furukawa, Yoko Eguchi, Shunya Kurokawa, Ryo Takemura, Taishiro Kishimoto

Abstract readSystematic ReviewMeta-AnalysisComparative Study
In one paragraph

Synthesis in Psychiatry and clinical neurosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mayu Fujikawa *Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4044-918X
Katsuhiko Hagi *Sumitomo Pharma Co, Ltd, Medical Affairs, Tokyo, Japan.
Shotaro KinoshitaHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
Akihiro TakamiyaHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
Mari IizukaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Shota FurukawaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Yoko EguchiDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Shunya KurokawaDepartment of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Ryo TakemuraClinical and Translational Research Center, Keio University Hospital, Tokyo, Japan.
Taishiro KishimotoHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0557-8648

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTelepsychiatry is increasingly integral to psychiatric practice. However, few reviews have examined the concordance between assessments conducted in telepsychiatric and face-to-face settings. This systematic review and meta-analysis evaluated the agreement between telepsychiatric and face-to-face settings in the diagnosis and symptom assessment of various psychiatric disorders.

methodsA literature search was conducted using MEDLINE/PubMed, Cochrane Library, Scopus, EMBASE, CINAHL, and PsycINFO. Studies evaluating the concordance between telepsychiatric and face-to-face settings in the diagnosis and symptom assessment of various psychiatric disorders were included and analyzed.

resultsOf the 6875 studies in the initial search, 22 studies that met the inclusion criteria were included in the analyses. The diagnostic concordance for 16 psychiatric disorders was "almost perfect" between the two settings (N = 16, n = 848, Cohen's κ = 0.824, confidence interval [CI] = 0.466 to 0.950, P < 0.001). Additionally, the concordance for the symptom rating scales between the two settings ranged from "substantial" in the Brief Psychiatric Rating Scale (N = 1, n = 533, Cohen's κ = 0.789, CI = 0.699 to 0.855, P < 0.001) to "almost perfect" in the Autism Diagnostic Observation Schedule (N = 1, n = 92, intraclass correlation coefficients = 0.943, CI = 0.798 to 0.985, P < 0.001).

conclusionsTelepsychiatry is highly concordant with face-to-face settings regarding psychiatric diagnoses and symptom assessment. In contrast, the present results also suggest that the suitability of telepsychiatry varies across disease types, specific symptoms, and assessment modalities. Although the present results must be interpreted with caution owing to the small number of studies for each assessment and disease, our findings suggest that telepsychiatry may have greater utility in psychiatric diagnostic assessment settings.

Indexed as

Mental DisordersPsychiatrySymptom AssessmentTelemedicineHumansconcordancediagnostic assessmentmeta‐analysissymptom assessmenttelepsychiatry

Identifiers

PMID40558077
PMCPMC12405819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.